nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—peripheral nervous system neoplasm—head and neck cancer	0.44	1	CtDrD
Tretinoin—RARB—head and neck cancer	0.27	0.781	CbGaD
Tretinoin—CYP1A1—head and neck cancer	0.0759	0.219	CbGaD
Tretinoin—CYP2A6—Fluorouracil—head and neck cancer	0.0191	0.277	CbGbCtD
Tretinoin—CYP3A7—Docetaxel—head and neck cancer	0.00998	0.145	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.00998	0.145	CbGbCtD
Tretinoin—CYP2C8—Fluorouracil—head and neck cancer	0.00943	0.137	CbGbCtD
Tretinoin—CYP3A5—Docetaxel—head and neck cancer	0.00749	0.108	CbGbCtD
Tretinoin—CYP2C9—Fluorouracil—head and neck cancer	0.00658	0.0953	CbGbCtD
Tretinoin—CYP3A4—Vinblastine—head and neck cancer	0.00354	0.0513	CbGbCtD
Tretinoin—CYP3A4—Docetaxel—head and neck cancer	0.00292	0.0423	CbGbCtD
Tretinoin—Isotretinoin—RARB—head and neck cancer	0.00123	0.353	CrCbGaD
Tretinoin—Acitretin—RARB—head and neck cancer	0.00104	0.3	CrCbGaD
Tretinoin—Alitretinoin—RARB—head and neck cancer	0.001	0.288	CrCbGaD
Tretinoin—RARG—tongue—head and neck cancer	0.000945	0.0443	CbGeAlD
Tretinoin—RARRES1—parotid gland—head and neck cancer	0.000906	0.0425	CbGeAlD
Tretinoin—CRABP2—mouth—head and neck cancer	0.000871	0.0408	CbGeAlD
Tretinoin—RARRES1—saliva-secreting gland—head and neck cancer	0.000868	0.0407	CbGeAlD
Tretinoin—CRABP1—neck—head and neck cancer	0.000823	0.0386	CbGeAlD
Tretinoin—ALDH1A1—mouth—head and neck cancer	0.000726	0.034	CbGeAlD
Tretinoin—RARRES1—trachea—head and neck cancer	0.000669	0.0314	CbGeAlD
Tretinoin—RXRG—neck—head and neck cancer	0.000651	0.0305	CbGeAlD
Tretinoin—RARG—mouth—head and neck cancer	0.000635	0.0298	CbGeAlD
Tretinoin—ALDH1A1—neck—head and neck cancer	0.00062	0.0291	CbGeAlD
Tretinoin—CRABP2—parotid gland—head and neck cancer	0.000606	0.0284	CbGeAlD
Tretinoin—CRABP1—connective tissue—head and neck cancer	0.00059	0.0277	CbGeAlD
Tretinoin—CRABP2—connective tissue—head and neck cancer	0.000534	0.025	CbGeAlD
Tretinoin—RARRES1—thyroid gland—head and neck cancer	0.000529	0.0248	CbGeAlD
Tretinoin—ALDH1A1—parotid gland—head and neck cancer	0.000505	0.0237	CbGeAlD
Tretinoin—CRABP1—trachea—head and neck cancer	0.000495	0.0232	CbGeAlD
Tretinoin—ALDH1A1—saliva-secreting gland—head and neck cancer	0.000484	0.0227	CbGeAlD
Tretinoin—CRABP2—trachea—head and neck cancer	0.000448	0.021	CbGeAlD
Tretinoin—ALDH1A1—connective tissue—head and neck cancer	0.000445	0.0209	CbGeAlD
Tretinoin—ALDH1A2—thyroid gland—head and neck cancer	0.000406	0.0191	CbGeAlD
Tretinoin—CRABP1—thyroid gland—head and neck cancer	0.000392	0.0184	CbGeAlD
Tretinoin—ALDH1A1—trachea—head and neck cancer	0.000373	0.0175	CbGeAlD
Tretinoin—ALDH1A2—head—head and neck cancer	0.00036	0.0169	CbGeAlD
Tretinoin—CRABP2—thyroid gland—head and neck cancer	0.000354	0.0166	CbGeAlD
Tretinoin—CRABP1—head—head and neck cancer	0.000348	0.0163	CbGeAlD
Tretinoin—RARRES1—lymph node—head and neck cancer	0.000329	0.0154	CbGeAlD
Tretinoin—ALDH1A1—lymphoid tissue—head and neck cancer	0.000325	0.0153	CbGeAlD
Tretinoin—RARB—thyroid gland—head and neck cancer	0.000317	0.0149	CbGeAlD
Tretinoin—CRABP2—head—head and neck cancer	0.000314	0.0147	CbGeAlD
Tretinoin—RXRA—head—head and neck cancer	0.000313	0.0147	CbGeAlD
Tretinoin—RXRG—thyroid gland—head and neck cancer	0.00031	0.0145	CbGeAlD
Tretinoin—ALDH1A1—thyroid gland—head and neck cancer	0.000295	0.0139	CbGeAlD
Tretinoin—RXRB—thyroid gland—head and neck cancer	0.000291	0.0137	CbGeAlD
Tretinoin—RARB—head—head and neck cancer	0.000281	0.0132	CbGeAlD
Tretinoin—RXRG—head—head and neck cancer	0.000275	0.0129	CbGeAlD
Tretinoin—RARA—lymphoid tissue—head and neck cancer	0.000268	0.0126	CbGeAlD
Tretinoin—ALDH1A1—head—head and neck cancer	0.000262	0.0123	CbGeAlD
Tretinoin—RARG—thyroid gland—head and neck cancer	0.000259	0.0121	CbGeAlD
Tretinoin—RXRB—head—head and neck cancer	0.000258	0.0121	CbGeAlD
Tretinoin—ALDH1A2—lymph node—head and neck cancer	0.000252	0.0118	CbGeAlD
Tretinoin—RARA—thyroid gland—head and neck cancer	0.000243	0.0114	CbGeAlD
Tretinoin—RARG—head—head and neck cancer	0.000229	0.0108	CbGeAlD
Tretinoin—CYP1A1—mouth—head and neck cancer	0.000218	0.0102	CbGeAlD
Tretinoin—RARA—head—head and neck cancer	0.000216	0.0101	CbGeAlD
Tretinoin—Vitamin A—CYP1A1—head and neck cancer	0.000205	0.0589	CrCbGaD
Tretinoin—RARB—lymph node—head and neck cancer	0.000197	0.00923	CbGeAlD
Tretinoin—ALDH1A1—lymph node—head and neck cancer	0.000183	0.0086	CbGeAlD
Tretinoin—RARG—lymph node—head and neck cancer	0.000161	0.00753	CbGeAlD
Tretinoin—Haemoglobin—Vinblastine—head and neck cancer	0.000158	0.00247	CcSEcCtD
Tretinoin—Haemorrhage—Vinblastine—head and neck cancer	0.000157	0.00246	CcSEcCtD
Tretinoin—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000156	0.00245	CcSEcCtD
Tretinoin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000156	0.00245	CcSEcCtD
Tretinoin—Hypoaesthesia—Vinblastine—head and neck cancer	0.000156	0.00245	CcSEcCtD
Tretinoin—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000156	0.00244	CcSEcCtD
Tretinoin—Pharyngitis—Vinblastine—head and neck cancer	0.000156	0.00244	CcSEcCtD
Tretinoin—Hearing impaired—Docetaxel—head and neck cancer	0.000155	0.00244	CcSEcCtD
Tretinoin—Stomatitis—Hydroxyurea—head and neck cancer	0.000155	0.00244	CcSEcCtD
Tretinoin—Bone pain—Docetaxel—head and neck cancer	0.000154	0.00242	CcSEcCtD
Tretinoin—Inflammation—Docetaxel—head and neck cancer	0.000153	0.00239	CcSEcCtD
Tretinoin—Cardiac failure—Fluorouracil—head and neck cancer	0.000153	0.00239	CcSEcCtD
Tretinoin—CYP1A1—parotid gland—head and neck cancer	0.000152	0.00713	CbGeAlD
Tretinoin—Lethargy—Fluorouracil—head and neck cancer	0.000152	0.00238	CcSEcCtD
Tretinoin—RARA—lymph node—head and neck cancer	0.000151	0.00708	CbGeAlD
Tretinoin—Respiratory failure—Docetaxel—head and neck cancer	0.000151	0.00236	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000149	0.00233	CcSEcCtD
Tretinoin—Osteoarthritis—Fluorouracil—head and neck cancer	0.000149	0.00233	CcSEcCtD
Tretinoin—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000148	0.00232	CcSEcCtD
Tretinoin—Hepatocellular injury—Docetaxel—head and neck cancer	0.000148	0.00232	CcSEcCtD
Tretinoin—Injection site reaction—Docetaxel—head and neck cancer	0.000147	0.00231	CcSEcCtD
Tretinoin—Haemoglobin—Hydroxyurea—head and neck cancer	0.000144	0.00225	CcSEcCtD
Tretinoin—Haemorrhage—Hydroxyurea—head and neck cancer	0.000143	0.00224	CcSEcCtD
Tretinoin—Hallucination—Hydroxyurea—head and neck cancer	0.000142	0.00223	CcSEcCtD
Tretinoin—Colitis—Docetaxel—head and neck cancer	0.000142	0.00223	CcSEcCtD
Tretinoin—Irritability—Fluorouracil—head and neck cancer	0.000142	0.00223	CcSEcCtD
Tretinoin—Cardiac arrest—Fluorouracil—head and neck cancer	0.000142	0.00222	CcSEcCtD
Tretinoin—Skin exfoliation—Docetaxel—head and neck cancer	0.000141	0.00222	CcSEcCtD
Tretinoin—Candida infection—Docetaxel—head and neck cancer	0.000141	0.00222	CcSEcCtD
Tretinoin—Alopecia—Vinblastine—head and neck cancer	0.000139	0.00217	CcSEcCtD
Tretinoin—Dry skin—Fluorouracil—head and neck cancer	0.000136	0.00214	CcSEcCtD
Tretinoin—Oesophagitis—Docetaxel—head and neck cancer	0.000135	0.00212	CcSEcCtD
Tretinoin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000133	0.00209	CcSEcCtD
Tretinoin—Lightheadedness—Docetaxel—head and neck cancer	0.000132	0.00208	CcSEcCtD
Tretinoin—Pulmonary oedema—Docetaxel—head and neck cancer	0.000132	0.00207	CcSEcCtD
Tretinoin—Angiopathy—Hydroxyurea—head and neck cancer	0.00013	0.00204	CcSEcCtD
Tretinoin—Dysphagia—Fluorouracil—head and neck cancer	0.000129	0.00202	CcSEcCtD
Tretinoin—Sepsis—Docetaxel—head and neck cancer	0.000128	0.00201	CcSEcCtD
Tretinoin—Chills—Hydroxyurea—head and neck cancer	0.000128	0.00201	CcSEcCtD
Tretinoin—CYP1A1—epithelium—head and neck cancer	0.000127	0.00596	CbGeAlD
Tretinoin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000127	0.00199	CcSEcCtD
Tretinoin—Alopecia—Hydroxyurea—head and neck cancer	0.000126	0.00198	CcSEcCtD
Tretinoin—Anaemia—Vinblastine—head and neck cancer	0.000126	0.00198	CcSEcCtD
Tretinoin—Phlebitis—Docetaxel—head and neck cancer	0.000125	0.00196	CcSEcCtD
Tretinoin—Erythema—Hydroxyurea—head and neck cancer	0.000125	0.00195	CcSEcCtD
Tretinoin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000124	0.00194	CcSEcCtD
Tretinoin—Malaise—Vinblastine—head and neck cancer	0.000123	0.00193	CcSEcCtD
Tretinoin—Swelling—Docetaxel—head and neck cancer	0.000122	0.00191	CcSEcCtD
Tretinoin—Deafness—Docetaxel—head and neck cancer	0.00012	0.00188	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00012	0.00187	CcSEcCtD
Tretinoin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000118	0.00186	CcSEcCtD
Tretinoin—Convulsion—Vinblastine—head and neck cancer	0.000118	0.00186	CcSEcCtD
Tretinoin—Hypertension—Vinblastine—head and neck cancer	0.000118	0.00185	CcSEcCtD
Tretinoin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000117	0.00184	CcSEcCtD
Tretinoin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000116	0.00181	CcSEcCtD
Tretinoin—Pneumonia—Fluorouracil—head and neck cancer	0.000115	0.00181	CcSEcCtD
Tretinoin—Anaemia—Hydroxyurea—head and neck cancer	0.000115	0.0018	CcSEcCtD
Tretinoin—Discomfort—Vinblastine—head and neck cancer	0.000115	0.0018	CcSEcCtD
Tretinoin—Infestation NOS—Fluorouracil—head and neck cancer	0.000115	0.0018	CcSEcCtD
Tretinoin—Infestation—Fluorouracil—head and neck cancer	0.000115	0.0018	CcSEcCtD
Tretinoin—Visual disturbance—Docetaxel—head and neck cancer	0.000113	0.00178	CcSEcCtD
Tretinoin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000113	0.00177	CcSEcCtD
Tretinoin—Renal impairment—Docetaxel—head and neck cancer	0.000113	0.00177	CcSEcCtD
Tretinoin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000112	0.00176	CcSEcCtD
Tretinoin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000112	0.00176	CcSEcCtD
Tretinoin—Dermatitis bullous—Docetaxel—head and neck cancer	0.000112	0.00176	CcSEcCtD
Tretinoin—CYP1A1—trachea—head and neck cancer	0.000112	0.00527	CbGeAlD
Tretinoin—Malaise—Hydroxyurea—head and neck cancer	0.000112	0.00176	CcSEcCtD
Tretinoin—Stomatitis—Fluorouracil—head and neck cancer	0.000112	0.00175	CcSEcCtD
Tretinoin—Urinary tract infection—Fluorouracil—head and neck cancer	0.000111	0.00175	CcSEcCtD
Tretinoin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000111	0.00175	CcSEcCtD
Tretinoin—Cardiac failure—Docetaxel—head and neck cancer	0.00011	0.00173	CcSEcCtD
Tretinoin—Lethargy—Docetaxel—head and neck cancer	0.00011	0.00172	CcSEcCtD
Tretinoin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000109	0.00171	CcSEcCtD
Tretinoin—Epistaxis—Fluorouracil—head and neck cancer	0.000108	0.0017	CcSEcCtD
Tretinoin—Convulsion—Hydroxyurea—head and neck cancer	0.000108	0.00169	CcSEcCtD
Tretinoin—Sinusitis—Fluorouracil—head and neck cancer	0.000108	0.00169	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000107	0.00168	CcSEcCtD
Tretinoin—Pain in extremity—Docetaxel—head and neck cancer	0.000107	0.00168	CcSEcCtD
Tretinoin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000107	0.00168	CcSEcCtD
Tretinoin—Anorexia—Vinblastine—head and neck cancer	0.000106	0.00167	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000105	0.00165	CcSEcCtD
Tretinoin—Discomfort—Hydroxyurea—head and neck cancer	0.000105	0.00164	CcSEcCtD
Tretinoin—Haemoglobin—Fluorouracil—head and neck cancer	0.000103	0.00162	CcSEcCtD
Tretinoin—Haemorrhage—Fluorouracil—head and neck cancer	0.000103	0.00161	CcSEcCtD
Tretinoin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000102	0.00161	CcSEcCtD
Tretinoin—Pharyngitis—Fluorouracil—head and neck cancer	0.000102	0.0016	CcSEcCtD
Tretinoin—Oedema—Hydroxyurea—head and neck cancer	0.000102	0.00159	CcSEcCtD
Tretinoin—Infection—Hydroxyurea—head and neck cancer	0.000101	0.00158	CcSEcCtD
Tretinoin—Paraesthesia—Vinblastine—head and neck cancer	0.0001	0.00157	CcSEcCtD
Tretinoin—Dehydration—Docetaxel—head and neck cancer	9.99e-05	0.00157	CcSEcCtD
Tretinoin—Nervous system disorder—Hydroxyurea—head and neck cancer	9.97e-05	0.00156	CcSEcCtD
Tretinoin—Thrombocytopenia—Hydroxyurea—head and neck cancer	9.95e-05	0.00156	CcSEcCtD
Tretinoin—Skin disorder—Hydroxyurea—head and neck cancer	9.87e-05	0.00155	CcSEcCtD
Tretinoin—Dry skin—Docetaxel—head and neck cancer	9.85e-05	0.00154	CcSEcCtD
Tretinoin—Anorexia—Hydroxyurea—head and neck cancer	9.69e-05	0.00152	CcSEcCtD
Tretinoin—Decreased appetite—Vinblastine—head and neck cancer	9.69e-05	0.00152	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	9.67e-05	0.00152	CcSEcCtD
Tretinoin—Nasopharyngitis—Docetaxel—head and neck cancer	9.61e-05	0.00151	CcSEcCtD
Tretinoin—Pain—Vinblastine—head and neck cancer	9.53e-05	0.00149	CcSEcCtD
Tretinoin—Constipation—Vinblastine—head and neck cancer	9.53e-05	0.00149	CcSEcCtD
Tretinoin—CYP2B6—lymphoid tissue—head and neck cancer	9.51e-05	0.00446	CbGeAlD
Tretinoin—Dysphagia—Docetaxel—head and neck cancer	9.29e-05	0.00146	CcSEcCtD
Tretinoin—Arrhythmia—Fluorouracil—head and neck cancer	9.2e-05	0.00144	CcSEcCtD
Tretinoin—Feeling abnormal—Vinblastine—head and neck cancer	9.18e-05	0.00144	CcSEcCtD
Tretinoin—Bronchospasm—Docetaxel—head and neck cancer	9.13e-05	0.00143	CcSEcCtD
Tretinoin—Gastrointestinal pain—Vinblastine—head and neck cancer	9.11e-05	0.00143	CcSEcCtD
Tretinoin—Alopecia—Fluorouracil—head and neck cancer	9.1e-05	0.00143	CcSEcCtD
Tretinoin—Dyspnoea—Hydroxyurea—head and neck cancer	9.06e-05	0.00142	CcSEcCtD
Tretinoin—Somnolence—Hydroxyurea—head and neck cancer	9.04e-05	0.00142	CcSEcCtD
Tretinoin—Erythema—Fluorouracil—head and neck cancer	8.96e-05	0.00141	CcSEcCtD
Tretinoin—Dyspepsia—Hydroxyurea—head and neck cancer	8.95e-05	0.0014	CcSEcCtD
Tretinoin—CYP1A1—thyroid gland—head and neck cancer	8.89e-05	0.00417	CbGeAlD
Tretinoin—Decreased appetite—Hydroxyurea—head and neck cancer	8.84e-05	0.00139	CcSEcCtD
Tretinoin—Abdominal pain—Vinblastine—head and neck cancer	8.81e-05	0.00138	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	8.77e-05	0.00138	CcSEcCtD
Tretinoin—Fatigue—Hydroxyurea—head and neck cancer	8.76e-05	0.00137	CcSEcCtD
Tretinoin—Constipation—Hydroxyurea—head and neck cancer	8.69e-05	0.00136	CcSEcCtD
Tretinoin—Pain—Hydroxyurea—head and neck cancer	8.69e-05	0.00136	CcSEcCtD
Tretinoin—Neutropenia—Docetaxel—head and neck cancer	8.68e-05	0.00136	CcSEcCtD
Tretinoin—Weight increased—Docetaxel—head and neck cancer	8.45e-05	0.00132	CcSEcCtD
Tretinoin—Vision blurred—Fluorouracil—head and neck cancer	8.45e-05	0.00132	CcSEcCtD
Tretinoin—Weight decreased—Docetaxel—head and neck cancer	8.4e-05	0.00132	CcSEcCtD
Tretinoin—Feeling abnormal—Hydroxyurea—head and neck cancer	8.38e-05	0.00131	CcSEcCtD
Tretinoin—Pneumonia—Docetaxel—head and neck cancer	8.33e-05	0.00131	CcSEcCtD
Tretinoin—Anaemia—Fluorouracil—head and neck cancer	8.28e-05	0.0013	CcSEcCtD
Tretinoin—Infestation NOS—Docetaxel—head and neck cancer	8.28e-05	0.0013	CcSEcCtD
Tretinoin—Infestation—Docetaxel—head and neck cancer	8.28e-05	0.0013	CcSEcCtD
Tretinoin—Hypersensitivity—Vinblastine—head and neck cancer	8.21e-05	0.00129	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	8.21e-05	0.00129	CcSEcCtD
Tretinoin—Acute coronary syndrome—Docetaxel—head and neck cancer	8.16e-05	0.00128	CcSEcCtD
Tretinoin—Renal failure—Docetaxel—head and neck cancer	8.14e-05	0.00128	CcSEcCtD
Tretinoin—Myocardial infarction—Docetaxel—head and neck cancer	8.12e-05	0.00127	CcSEcCtD
Tretinoin—Neuropathy peripheral—Docetaxel—head and neck cancer	8.12e-05	0.00127	CcSEcCtD
Tretinoin—Stomatitis—Docetaxel—head and neck cancer	8.07e-05	0.00127	CcSEcCtD
Tretinoin—Conjunctivitis—Docetaxel—head and neck cancer	8.05e-05	0.00126	CcSEcCtD
Tretinoin—Body temperature increased—Hydroxyurea—head and neck cancer	8.03e-05	0.00126	CcSEcCtD
Tretinoin—Asthenia—Vinblastine—head and neck cancer	8e-05	0.00125	CcSEcCtD
Tretinoin—CYP1A1—head—head and neck cancer	7.89e-05	0.0037	CbGeAlD
Tretinoin—Epistaxis—Docetaxel—head and neck cancer	7.81e-05	0.00122	CcSEcCtD
Tretinoin—Convulsion—Fluorouracil—head and neck cancer	7.77e-05	0.00122	CcSEcCtD
Tretinoin—Agranulocytosis—Docetaxel—head and neck cancer	7.73e-05	0.00121	CcSEcCtD
Tretinoin—CYP2B6—head—head and neck cancer	7.66e-05	0.00359	CbGeAlD
Tretinoin—Chest pain—Fluorouracil—head and neck cancer	7.63e-05	0.0012	CcSEcCtD
Tretinoin—Myalgia—Fluorouracil—head and neck cancer	7.63e-05	0.0012	CcSEcCtD
Tretinoin—Diarrhoea—Vinblastine—head and neck cancer	7.63e-05	0.0012	CcSEcCtD
Tretinoin—Discomfort—Fluorouracil—head and neck cancer	7.54e-05	0.00118	CcSEcCtD
Tretinoin—Hypersensitivity—Hydroxyurea—head and neck cancer	7.49e-05	0.00117	CcSEcCtD
Tretinoin—Haemoglobin—Docetaxel—head and neck cancer	7.47e-05	0.00117	CcSEcCtD
Tretinoin—Haemorrhage—Docetaxel—head and neck cancer	7.43e-05	0.00117	CcSEcCtD
Tretinoin—Hepatitis—Docetaxel—head and neck cancer	7.43e-05	0.00117	CcSEcCtD
Tretinoin—Hypoaesthesia—Docetaxel—head and neck cancer	7.39e-05	0.00116	CcSEcCtD
Tretinoin—Confusional state—Fluorouracil—head and neck cancer	7.38e-05	0.00116	CcSEcCtD
Tretinoin—Pharyngitis—Docetaxel—head and neck cancer	7.38e-05	0.00116	CcSEcCtD
Tretinoin—Dizziness—Vinblastine—head and neck cancer	7.37e-05	0.00116	CcSEcCtD
Tretinoin—Urinary tract disorder—Docetaxel—head and neck cancer	7.34e-05	0.00115	CcSEcCtD
Tretinoin—Oedema peripheral—Docetaxel—head and neck cancer	7.32e-05	0.00115	CcSEcCtD
Tretinoin—Oedema—Fluorouracil—head and neck cancer	7.32e-05	0.00115	CcSEcCtD
Tretinoin—Anaphylactic shock—Fluorouracil—head and neck cancer	7.32e-05	0.00115	CcSEcCtD
Tretinoin—Asthenia—Hydroxyurea—head and neck cancer	7.29e-05	0.00114	CcSEcCtD
Tretinoin—Urethral disorder—Docetaxel—head and neck cancer	7.29e-05	0.00114	CcSEcCtD
Tretinoin—Infection—Fluorouracil—head and neck cancer	7.27e-05	0.00114	CcSEcCtD
Tretinoin—Nervous system disorder—Fluorouracil—head and neck cancer	7.17e-05	0.00112	CcSEcCtD
Tretinoin—Thrombocytopenia—Fluorouracil—head and neck cancer	7.16e-05	0.00112	CcSEcCtD
Tretinoin—Visual impairment—Docetaxel—head and neck cancer	7.16e-05	0.00112	CcSEcCtD
Tretinoin—Tachycardia—Fluorouracil—head and neck cancer	7.14e-05	0.00112	CcSEcCtD
Tretinoin—Vomiting—Vinblastine—head and neck cancer	7.09e-05	0.00111	CcSEcCtD
Tretinoin—Erythema multiforme—Docetaxel—head and neck cancer	7.03e-05	0.0011	CcSEcCtD
Tretinoin—Headache—Vinblastine—head and neck cancer	6.98e-05	0.00109	CcSEcCtD
Tretinoin—Anorexia—Fluorouracil—head and neck cancer	6.97e-05	0.00109	CcSEcCtD
Tretinoin—Diarrhoea—Hydroxyurea—head and neck cancer	6.95e-05	0.00109	CcSEcCtD
Tretinoin—Eye disorder—Docetaxel—head and neck cancer	6.95e-05	0.00109	CcSEcCtD
Tretinoin—Flushing—Docetaxel—head and neck cancer	6.9e-05	0.00108	CcSEcCtD
Tretinoin—Hypotension—Fluorouracil—head and neck cancer	6.84e-05	0.00107	CcSEcCtD
Tretinoin—Angiopathy—Docetaxel—head and neck cancer	6.74e-05	0.00106	CcSEcCtD
Tretinoin—Dizziness—Hydroxyurea—head and neck cancer	6.72e-05	0.00105	CcSEcCtD
Tretinoin—Chills—Docetaxel—head and neck cancer	6.67e-05	0.00105	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	6.67e-05	0.00105	CcSEcCtD
Tretinoin—Arrhythmia—Docetaxel—head and neck cancer	6.64e-05	0.00104	CcSEcCtD
Tretinoin—Nausea—Vinblastine—head and neck cancer	6.62e-05	0.00104	CcSEcCtD
Tretinoin—Insomnia—Fluorouracil—head and neck cancer	6.62e-05	0.00104	CcSEcCtD
Tretinoin—Paraesthesia—Fluorouracil—head and neck cancer	6.57e-05	0.00103	CcSEcCtD
Tretinoin—Alopecia—Docetaxel—head and neck cancer	6.57e-05	0.00103	CcSEcCtD
Tretinoin—Dyspnoea—Fluorouracil—head and neck cancer	6.52e-05	0.00102	CcSEcCtD
Tretinoin—Mental disorder—Docetaxel—head and neck cancer	6.51e-05	0.00102	CcSEcCtD
Tretinoin—Somnolence—Fluorouracil—head and neck cancer	6.5e-05	0.00102	CcSEcCtD
Tretinoin—Malnutrition—Docetaxel—head and neck cancer	6.47e-05	0.00101	CcSEcCtD
Tretinoin—Erythema—Docetaxel—head and neck cancer	6.47e-05	0.00101	CcSEcCtD
Tretinoin—Vomiting—Hydroxyurea—head and neck cancer	6.46e-05	0.00101	CcSEcCtD
Tretinoin—Dyspepsia—Fluorouracil—head and neck cancer	6.44e-05	0.00101	CcSEcCtD
Tretinoin—Rash—Hydroxyurea—head and neck cancer	6.41e-05	0.001	CcSEcCtD
Tretinoin—Dermatitis—Hydroxyurea—head and neck cancer	6.4e-05	0.001	CcSEcCtD
Tretinoin—Headache—Hydroxyurea—head and neck cancer	6.37e-05	0.000998	CcSEcCtD
Tretinoin—Decreased appetite—Fluorouracil—head and neck cancer	6.36e-05	0.000997	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	6.32e-05	0.00099	CcSEcCtD
Tretinoin—Back pain—Docetaxel—head and neck cancer	6.26e-05	0.000981	CcSEcCtD
Tretinoin—Pain—Fluorouracil—head and neck cancer	6.26e-05	0.000981	CcSEcCtD
Tretinoin—Nausea—Hydroxyurea—head and neck cancer	6.04e-05	0.000947	CcSEcCtD
Tretinoin—Feeling abnormal—Fluorouracil—head and neck cancer	6.03e-05	0.000945	CcSEcCtD
Tretinoin—Anaemia—Docetaxel—head and neck cancer	5.98e-05	0.000938	CcSEcCtD
Tretinoin—Urticaria—Fluorouracil—head and neck cancer	5.81e-05	0.000911	CcSEcCtD
Tretinoin—Syncope—Docetaxel—head and neck cancer	5.8e-05	0.00091	CcSEcCtD
Tretinoin—Body temperature increased—Fluorouracil—head and neck cancer	5.78e-05	0.000907	CcSEcCtD
Tretinoin—Palpitations—Docetaxel—head and neck cancer	5.72e-05	0.000896	CcSEcCtD
Tretinoin—Loss of consciousness—Docetaxel—head and neck cancer	5.69e-05	0.000892	CcSEcCtD
Tretinoin—Cough—Docetaxel—head and neck cancer	5.65e-05	0.000885	CcSEcCtD
Tretinoin—Convulsion—Docetaxel—head and neck cancer	5.61e-05	0.000879	CcSEcCtD
Tretinoin—Hypertension—Docetaxel—head and neck cancer	5.59e-05	0.000876	CcSEcCtD
Tretinoin—CYP1A1—lymph node—head and neck cancer	5.52e-05	0.00259	CbGeAlD
Tretinoin—Arthralgia—Docetaxel—head and neck cancer	5.51e-05	0.000864	CcSEcCtD
Tretinoin—Chest pain—Docetaxel—head and neck cancer	5.51e-05	0.000864	CcSEcCtD
Tretinoin—Myalgia—Docetaxel—head and neck cancer	5.51e-05	0.000864	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	5.47e-05	0.000858	CcSEcCtD
Tretinoin—Hypersensitivity—Fluorouracil—head and neck cancer	5.39e-05	0.000845	CcSEcCtD
Tretinoin—Dry mouth—Docetaxel—head and neck cancer	5.39e-05	0.000845	CcSEcCtD
Tretinoin—Confusional state—Docetaxel—head and neck cancer	5.32e-05	0.000835	CcSEcCtD
Tretinoin—Anaphylactic shock—Docetaxel—head and neck cancer	5.28e-05	0.000828	CcSEcCtD
Tretinoin—Oedema—Docetaxel—head and neck cancer	5.28e-05	0.000828	CcSEcCtD
Tretinoin—Infection—Docetaxel—head and neck cancer	5.25e-05	0.000823	CcSEcCtD
Tretinoin—Shock—Docetaxel—head and neck cancer	5.19e-05	0.000815	CcSEcCtD
Tretinoin—Nervous system disorder—Docetaxel—head and neck cancer	5.18e-05	0.000812	CcSEcCtD
Tretinoin—Pruritus—Fluorouracil—head and neck cancer	5.18e-05	0.000812	CcSEcCtD
Tretinoin—Thrombocytopenia—Docetaxel—head and neck cancer	5.17e-05	0.000811	CcSEcCtD
Tretinoin—Tachycardia—Docetaxel—head and neck cancer	5.15e-05	0.000808	CcSEcCtD
Tretinoin—Skin disorder—Docetaxel—head and neck cancer	5.13e-05	0.000804	CcSEcCtD
Tretinoin—Anorexia—Docetaxel—head and neck cancer	5.03e-05	0.000789	CcSEcCtD
Tretinoin—Diarrhoea—Fluorouracil—head and neck cancer	5.01e-05	0.000785	CcSEcCtD
Tretinoin—Hypotension—Docetaxel—head and neck cancer	4.93e-05	0.000774	CcSEcCtD
Tretinoin—Dizziness—Fluorouracil—head and neck cancer	4.84e-05	0.000759	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	4.81e-05	0.000754	CcSEcCtD
Tretinoin—Insomnia—Docetaxel—head and neck cancer	4.78e-05	0.000749	CcSEcCtD
Tretinoin—Paraesthesia—Docetaxel—head and neck cancer	4.74e-05	0.000743	CcSEcCtD
Tretinoin—Dyspnoea—Docetaxel—head and neck cancer	4.71e-05	0.000738	CcSEcCtD
Tretinoin—Somnolence—Docetaxel—head and neck cancer	4.69e-05	0.000736	CcSEcCtD
Tretinoin—Vomiting—Fluorouracil—head and neck cancer	4.65e-05	0.000729	CcSEcCtD
Tretinoin—Dyspepsia—Docetaxel—head and neck cancer	4.65e-05	0.000729	CcSEcCtD
Tretinoin—Rash—Fluorouracil—head and neck cancer	4.61e-05	0.000723	CcSEcCtD
Tretinoin—Dermatitis—Fluorouracil—head and neck cancer	4.61e-05	0.000723	CcSEcCtD
Tretinoin—Decreased appetite—Docetaxel—head and neck cancer	4.59e-05	0.00072	CcSEcCtD
Tretinoin—Headache—Fluorouracil—head and neck cancer	4.58e-05	0.000719	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Docetaxel—head and neck cancer	4.56e-05	0.000715	CcSEcCtD
Tretinoin—Fatigue—Docetaxel—head and neck cancer	4.55e-05	0.000714	CcSEcCtD
Tretinoin—Pain—Docetaxel—head and neck cancer	4.52e-05	0.000708	CcSEcCtD
Tretinoin—Constipation—Docetaxel—head and neck cancer	4.52e-05	0.000708	CcSEcCtD
Tretinoin—Feeling abnormal—Docetaxel—head and neck cancer	4.35e-05	0.000682	CcSEcCtD
Tretinoin—Nausea—Fluorouracil—head and neck cancer	4.35e-05	0.000681	CcSEcCtD
Tretinoin—Gastrointestinal pain—Docetaxel—head and neck cancer	4.32e-05	0.000677	CcSEcCtD
Tretinoin—Abdominal pain—Docetaxel—head and neck cancer	4.17e-05	0.000654	CcSEcCtD
Tretinoin—Body temperature increased—Docetaxel—head and neck cancer	4.17e-05	0.000654	CcSEcCtD
Tretinoin—Hypersensitivity—Docetaxel—head and neck cancer	3.89e-05	0.00061	CcSEcCtD
Tretinoin—Asthenia—Docetaxel—head and neck cancer	3.79e-05	0.000594	CcSEcCtD
Tretinoin—Pruritus—Docetaxel—head and neck cancer	3.74e-05	0.000586	CcSEcCtD
Tretinoin—Diarrhoea—Docetaxel—head and neck cancer	3.61e-05	0.000566	CcSEcCtD
Tretinoin—Dizziness—Docetaxel—head and neck cancer	3.49e-05	0.000547	CcSEcCtD
Tretinoin—Vomiting—Docetaxel—head and neck cancer	3.36e-05	0.000526	CcSEcCtD
Tretinoin—Rash—Docetaxel—head and neck cancer	3.33e-05	0.000522	CcSEcCtD
Tretinoin—Dermatitis—Docetaxel—head and neck cancer	3.33e-05	0.000522	CcSEcCtD
Tretinoin—Headache—Docetaxel—head and neck cancer	3.31e-05	0.000519	CcSEcCtD
Tretinoin—Nausea—Docetaxel—head and neck cancer	3.14e-05	0.000492	CcSEcCtD
Tretinoin—CRABP2—Metabolism—GSTM1—head and neck cancer	2.44e-05	0.000438	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GSTM1—head and neck cancer	2.44e-05	0.000438	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—UROD—head and neck cancer	2.42e-05	0.000434	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—STAT3—head and neck cancer	2.38e-05	0.000426	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.36e-05	0.000423	CbGpPWpGaD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	2.34e-05	0.00042	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	2.34e-05	0.00042	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GPX1—head and neck cancer	2.34e-05	0.000419	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GPX1—head and neck cancer	2.34e-05	0.000419	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GPX1—head and neck cancer	2.34e-05	0.000419	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CYP1A1—head and neck cancer	2.32e-05	0.000415	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CYP1A1—head and neck cancer	2.32e-05	0.000415	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CYP1A1—head and neck cancer	2.32e-05	0.000415	CbGpPWpGaD
Tretinoin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	2.31e-05	0.000414	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	2.31e-05	0.000414	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	2.29e-05	0.00041	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	2.26e-05	0.000405	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.25e-05	0.000404	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.24e-05	0.000402	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	2.22e-05	0.000398	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	2.19e-05	0.000393	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	2.17e-05	0.000389	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	2.16e-05	0.000388	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.16e-05	0.000387	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—NAT2—head and neck cancer	2.16e-05	0.000386	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	2.14e-05	0.000384	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	2.13e-05	0.000382	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	2.13e-05	0.000381	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.03e-05	0.000363	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2e-05	0.000359	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—NOTCH1—head and neck cancer	2e-05	0.000358	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	1.99e-05	0.000357	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.98e-05	0.000356	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	1.98e-05	0.000355	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	1.96e-05	0.000351	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.95e-05	0.00035	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—UROD—head and neck cancer	1.95e-05	0.00035	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—UROD—head and neck cancer	1.91e-05	0.000342	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.9e-05	0.000341	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.9e-05	0.000341	CbGpPWpGaD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	1.9e-05	0.00034	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—NAT2—head and neck cancer	1.89e-05	0.000338	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	1.88e-05	0.000337	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	1.85e-05	0.000332	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—UROD—head and neck cancer	1.8e-05	0.000323	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.77e-05	0.000316	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—RARB—head and neck cancer	1.76e-05	0.000316	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.67e-05	0.000299	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—DPYD—head and neck cancer	1.66e-05	0.000297	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—UROD—head and neck cancer	1.65e-05	0.000296	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NAT2—head and neck cancer	1.65e-05	0.000296	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	1.61e-05	0.000289	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—NOTCH1—head and neck cancer	1.61e-05	0.000289	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—YAP1—head and neck cancer	1.6e-05	0.000287	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	1.59e-05	0.000285	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.59e-05	0.000285	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.59e-05	0.000285	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.59e-05	0.000285	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.57e-05	0.000282	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—YAP1—head and neck cancer	1.57e-05	0.000281	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	1.53e-05	0.000274	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	1.51e-05	0.00027	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—NOTCH1—head and neck cancer	1.5e-05	0.000269	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NAT2—head and neck cancer	1.5e-05	0.000268	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—NOTCH1—head and neck cancer	1.47e-05	0.000264	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—DPYD—head and neck cancer	1.45e-05	0.000259	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—NOTCH1—head and neck cancer	1.45e-05	0.000259	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—NOTCH1—head and neck cancer	1.41e-05	0.000253	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.4e-05	0.000251	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—NOTCH1—head and neck cancer	1.39e-05	0.000248	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—NOTCH1—head and neck cancer	1.39e-05	0.000248	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.38e-05	0.000247	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTGS2—head and neck cancer	1.38e-05	0.000247	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGS2—head and neck cancer	1.38e-05	0.000247	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGS2—head and neck cancer	1.38e-05	0.000247	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—YAP1—head and neck cancer	1.37e-05	0.000246	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—UROD—head and neck cancer	1.35e-05	0.000241	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.33e-05	0.000239	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—DPYD—head and neck cancer	1.31e-05	0.000235	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.28e-05	0.00023	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—YAP1—head and neck cancer	1.25e-05	0.000223	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTEN—head and neck cancer	1.2e-05	0.000215	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTEN—head and neck cancer	1.2e-05	0.000215	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTEN—head and neck cancer	1.2e-05	0.000215	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.18e-05	0.000211	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.13e-05	0.000202	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—MAPK3—head and neck cancer	1.11e-05	0.000198	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NAT2—head and neck cancer	1.1e-05	0.000197	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.06e-05	0.000191	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.05e-05	0.000188	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.04e-05	0.000187	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.03e-05	0.000184	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.01e-05	0.000181	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NAT2—head and neck cancer	1.01e-05	0.00018	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	9.95e-06	0.000178	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—DPYD—head and neck cancer	9.62e-06	0.000172	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—TYMS—head and neck cancer	9.43e-06	0.000169	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.36e-06	0.000168	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GSTM1—head and neck cancer	9.32e-06	0.000167	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—YAP1—head and neck cancer	9.13e-06	0.000164	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GPX1—head and neck cancer	8.93e-06	0.00016	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MAPK3—head and neck cancer	8.91e-06	0.00016	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—UROD—head and neck cancer	8.88e-06	0.000159	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP1A1—head and neck cancer	8.84e-06	0.000158	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—DPYD—head and neck cancer	8.82e-06	0.000158	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PIK3CA—head and neck cancer	8.47e-06	0.000152	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PIK3CA—head and neck cancer	8.47e-06	0.000152	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PIK3CA—head and neck cancer	8.47e-06	0.000152	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—YAP1—head and neck cancer	8.37e-06	0.00015	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—head and neck cancer	8.26e-06	0.000148	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TYMS—head and neck cancer	8.24e-06	0.000148	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—STAT3—head and neck cancer	8.17e-06	0.000146	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.16e-06	0.000146	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MAPK3—head and neck cancer	8.15e-06	0.000146	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GSTM1—head and neck cancer	8.15e-06	0.000146	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NAT2—head and neck cancer	8.11e-06	0.000145	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MAPK3—head and neck cancer	7.99e-06	0.000143	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.96e-06	0.000143	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NAT2—head and neck cancer	7.93e-06	0.000142	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MAPK3—head and neck cancer	7.81e-06	0.00014	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GPX1—head and neck cancer	7.8e-06	0.00014	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP1A1—head and neck cancer	7.72e-06	0.000138	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MAPK3—head and neck cancer	7.66e-06	0.000137	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MAPK3—head and neck cancer	7.66e-06	0.000137	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NAT2—head and neck cancer	7.49e-06	0.000134	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TYMS—head and neck cancer	7.48e-06	0.000134	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—AKT1—head and neck cancer	7.46e-06	0.000134	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MAPK1—head and neck cancer	7.43e-06	0.000133	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EGFR—head and neck cancer	7.43e-06	0.000133	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GSTM1—head and neck cancer	7.39e-06	0.000133	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.29e-06	0.000131	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.26e-06	0.00013	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NOTCH1—head and neck cancer	7.22e-06	0.000129	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.22e-06	0.000129	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—DPYD—head and neck cancer	7.11e-06	0.000127	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GPX1—head and neck cancer	7.08e-06	0.000127	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP1A1—head and neck cancer	7.01e-06	0.000126	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—DPYD—head and neck cancer	6.95e-06	0.000125	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AKT1—head and neck cancer	6.92e-06	0.000124	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AKT1—head and neck cancer	6.92e-06	0.000124	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AKT1—head and neck cancer	6.92e-06	0.000124	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NAT2—head and neck cancer	6.87e-06	0.000123	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—YAP1—head and neck cancer	6.75e-06	0.000121	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—YAP1—head and neck cancer	6.6e-06	0.000118	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—DPYD—head and neck cancer	6.57e-06	0.000118	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—YAP1—head and neck cancer	6.23e-06	0.000112	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—DPYD—head and neck cancer	6.02e-06	0.000108	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—AKT1—head and neck cancer	6.01e-06	0.000108	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HRAS—head and neck cancer	5.97e-06	0.000107	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.94e-06	0.000106	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.88e-06	0.000105	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.76e-06	0.000103	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—YAP1—head and neck cancer	5.71e-06	0.000102	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NAT2—head and neck cancer	5.59e-06	0.0001	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—head and neck cancer	5.5e-06	9.85e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TYMS—head and neck cancer	5.48e-06	9.82e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTM1—head and neck cancer	5.42e-06	9.71e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—head and neck cancer	5.39e-06	9.66e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—head and neck cancer	5.27e-06	9.44e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—head and neck cancer	5.26e-06	9.42e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GPX1—head and neck cancer	5.19e-06	9.3e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—head and neck cancer	5.17e-06	9.27e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—head and neck cancer	5.17e-06	9.27e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1A1—head and neck cancer	5.14e-06	9.2e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TYMS—head and neck cancer	5.02e-06	9e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTM1—head and neck cancer	4.97e-06	8.9e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—DPYD—head and neck cancer	4.9e-06	8.78e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GPX1—head and neck cancer	4.76e-06	8.52e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1A1—head and neck cancer	4.71e-06	8.44e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.68e-06	8.39e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—YAP1—head and neck cancer	4.65e-06	8.33e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—head and neck cancer	4.59e-06	8.23e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTEN—head and neck cancer	4.58e-06	8.21e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.29e-06	7.69e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—head and neck cancer	4.17e-06	7.47e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.08e-06	7.32e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TYMS—head and neck cancer	4.05e-06	7.26e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTEN—head and neck cancer	4.01e-06	7.18e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—head and neck cancer	4.01e-06	7.18e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MAPK3—head and neck cancer	3.99e-06	7.16e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TYMS—head and neck cancer	3.96e-06	7.1e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—head and neck cancer	3.92e-06	7.02e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GPX1—head and neck cancer	3.84e-06	6.88e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1A1—head and neck cancer	3.8e-06	6.81e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GPX1—head and neck cancer	3.75e-06	6.72e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.74e-06	6.71e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TYMS—head and neck cancer	3.74e-06	6.71e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1A1—head and neck cancer	3.71e-06	6.65e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—head and neck cancer	3.7e-06	6.63e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NAT2—head and neck cancer	3.69e-06	6.61e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTEN—head and neck cancer	3.64e-06	6.51e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GPX1—head and neck cancer	3.54e-06	6.35e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.49e-06	6.26e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TYMS—head and neck cancer	3.43e-06	6.15e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—head and neck cancer	3.39e-06	6.08e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GPX1—head and neck cancer	3.25e-06	5.82e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—head and neck cancer	3.23e-06	5.79e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—DPYD—head and neck cancer	3.23e-06	5.79e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A1—head and neck cancer	3.22e-06	5.76e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—YAP1—head and neck cancer	3.07e-06	5.5e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—head and neck cancer	3.05e-06	5.47e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.05e-06	5.46e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.88e-06	5.16e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—head and neck cancer	2.83e-06	5.07e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—head and neck cancer	2.8e-06	5.02e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TYMS—head and neck cancer	2.79e-06	5e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.76e-06	4.95e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—head and neck cancer	2.69e-06	4.83e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTEN—head and neck cancer	2.66e-06	4.77e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPX1—head and neck cancer	2.64e-06	4.74e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.64e-06	4.73e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—head and neck cancer	2.64e-06	4.73e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.62e-06	4.69e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—head and neck cancer	2.56e-06	4.6e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTEN—head and neck cancer	2.44e-06	4.38e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—head and neck cancer	2.31e-06	4.14e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—head and neck cancer	2.26e-06	4.05e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.21e-06	3.96e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.15e-06	3.85e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—head and neck cancer	2.1e-06	3.75e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—head and neck cancer	2.09e-06	3.74e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTEN—head and neck cancer	1.97e-06	3.53e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTEN—head and neck cancer	1.93e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.91e-06	3.43e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.88e-06	3.37e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TYMS—head and neck cancer	1.84e-06	3.3e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.82e-06	3.26e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTEN—head and neck cancer	1.82e-06	3.26e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX1—head and neck cancer	1.74e-06	3.12e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.73e-06	3.09e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—head and neck cancer	1.72e-06	3.09e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTEN—head and neck cancer	1.67e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.56e-06	2.79e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—head and neck cancer	1.53e-06	2.75e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—head and neck cancer	1.41e-06	2.52e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.39e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.36e-06	2.43e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTEN—head and neck cancer	1.36e-06	2.43e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—head and neck cancer	1.28e-06	2.3e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.18e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—head and neck cancer	1.14e-06	2.03e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—head and neck cancer	1.11e-06	1.99e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—head and neck cancer	1.05e-06	1.88e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.03e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—head and neck cancer	9.61e-07	1.72e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—head and neck cancer	9.57e-07	1.72e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTEN—head and neck cancer	8.95e-07	1.6e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—head and neck cancer	7.82e-07	1.4e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	6.31e-07	1.13e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—head and neck cancer	5.16e-07	9.24e-06	CbGpPWpGaD
